IDEAYA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2023 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 10th, 2023 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is entered into between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Andres Ruiz Briseno (“Executive” and, together with the Company, the “Parties”) effective as of July 1, 2023 (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement between Executive and the Company dated as of November 1, 2021 (“Prior Agreement”).
IDEAYA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2023 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 7th, 2023 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is entered into between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Darrin Beaupre, M.D., PhD (“Executive” and, together with the Company, the “Parties”) effective as of November 21, 2022 (the “Effective Date”).
PARAGON 28, INC. EMPLOYMENT AGREEMENTEmployment Agreement • October 8th, 2021 • Paragon 28, Inc. • Surgical & medical instruments & apparatus • Colorado
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into as of October 8, 2021 (the “Effective Date”), is between Paragon 28, Inc., a Delaware corporation (the “Company”) and Matthew Jarboe (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain employment offer letter agreement between Executive and the Company dated as of January 1, 2020 (“Offer Letter”).
PARAGON 28, INC. EMPLOYMENT AGREEMENTEmployment Agreement • October 8th, 2021 • Paragon 28, Inc. • Surgical & medical instruments & apparatus • Colorado
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into as of October 8, 2021 (the “Effective Date”), is between Paragon 28, Inc., a Delaware corporation (the “Company”) and Stephen M. Deitsch (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain employment offer letter agreement between Executive and the Company dated as of September 28, 2020 (“Offer Letter”).
PARAGON 28, INC. EMPLOYMENT AGREEMENTEmployment Agreement • October 8th, 2021 • Paragon 28, Inc. • Surgical & medical instruments & apparatus • Colorado
Contract Type FiledOctober 8th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into as of October 8, 2021 (the “Effective Date”), is between Paragon 28, Inc., a Delaware corporation (the “Company”) and Albert DaCosta (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain employment offer letter agreement between Executive and the Company dated as of January 1, 2020 (“Offer Letter”).
AMPLITUDE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 30th, 2021 • Amplitude, Inc. • Services-prepackaged software • California
Contract Type FiledAugust 30th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into as of [ ], 20[ ] (the “Effective Date”), is between Amplitude, Inc., a Delaware corporation (the “Company”) and [ ] (“Executive” and, together with the Company, the “Parties”). [This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of [ ] (“Offer Letter”).]
IDEAYA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2021 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 23rd, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is entered into between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Jason S. Throne (“Executive” and, together with the Company, the “Parties”) effective as of February 24, 2021 (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement between Executive and the Company dated as of October 9, 2019 (“Prior Agreement”)
EARGO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2020 • Eargo, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledSeptember 25th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), dated September 25, 2020, is between Eargo, Inc., a Delaware corporation (the “Company”) and Adam Laponis (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the closing of the initial public offering of the Company’s common stock (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of May 8, 2019 (“Offer Letter”) effective as of the Effective Date.
EARGO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2020 • Eargo, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledSeptember 25th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), dated September 25, 2020, is between Eargo, Inc., a Delaware corporation (the “Company”) and Christian Gormsen (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the closing of the initial public offering of the Company’s common stock (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of February 17, 2016 (“Offer Letter”) effective as of the Effective Date.
EARGO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 25th, 2020 • Eargo, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledSeptember 25th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), dated September 25, 2020, is between Eargo, Inc., a Delaware corporation (the “Company”) and William Brownie (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the closing of the initial public offering of the Company’s common stock (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of August 18, 2016 (“Offer Letter”) effective as of the Effective Date.
IDEAYA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2020 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 24th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is entered into between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Jason S. Throne (“Executive” and, together with the Company, the “Parties”) effective as of October 9, 2019 (the “Effective Date”).
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • January 17th, 2020 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJanuary 17th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into effective as of December 18, 2019 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Margaret Horn (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of November 9, 2014 (“Offer Letter”).
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • January 17th, 2020 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJanuary 17th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into effective as of December 18, 2019 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Mark Goldsmith (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of October 29, 2014 (“Offer Letter”).
REVOLUTION MEDICINES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • January 17th, 2020 • Revolution Medicines, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJanuary 17th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into effective as of December 18, 2019 (the “Effective Date”), is between Revolution Medicines, Inc., a Delaware corporation (the “Company”) and Steve Kelsey (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of January 23, 2017 (“Offer Letter”).
IDEAYA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2019 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 17th, 2019 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), entered into as of May 15, 2019, is between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Jeffrey Hager (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of October 28, 2015 (“Offer Letter”).